1. A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology
- Author
-
Giusti, R M., Rutter, J L., Duray, P H., Freedman, L S., Konichezky, M., Fisher - Fischbein, J., Greene, M.H., Maslansky, B., Fischbein, A., Gruber, S.B., Rennert, G., Ronchetti, R.D., Hewitt, S.M., Struewing, J.P., and Iscovich, J.
- Subjects
Gene mutations -- Physiological aspects -- Health aspects -- Research -- Analysis -- Genetic aspects ,Genetic research -- Analysis -- Physiological aspects -- Genetic aspects -- Health aspects ,Prostate cancer -- Health aspects -- Genetic aspects -- Care and treatment -- Demographic aspects -- Research ,Cancer patients -- Demographic aspects -- Genetic aspects -- Health aspects -- Care and treatment ,Ashkenazim -- Genetic aspects -- Health aspects -- Physiological aspects -- Research -- Analysis ,Medical genetics -- Research -- Health aspects -- Analysis -- Physiological aspects ,Health ,Care and treatment ,Physiological aspects ,Analysis ,Research ,Genetic aspects ,Demographic aspects ,Health aspects - Abstract
J Med Genet 2003;40:787-792 The magnitude of the risk of prostate cancer among Ashkenazi Jewish carriers of the common mutations in the BRCA1 and BRCA2 genes, the so-called Ashkenazi BRCA [...]
- Published
- 2003